vs

Side-by-side financial comparison of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) and ROYAL GOLD INC (RGLD). Click either name above to swap in a different company.

ROYAL GOLD INC is the larger business by last-quarter revenue ($375.3M vs $264.0M, roughly 1.4× ARROWHEAD PHARMACEUTICALS, INC.). ROYAL GOLD INC runs the higher net margin — 24.9% vs 11.7%, a 13.3% gap on every dollar of revenue. On growth, ARROWHEAD PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (10461.3% vs 85.3%).

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Royal Gold Inc. is a leading precious metals streaming and royalty firm that acquires and manages a diversified portfolio of streaming interests, royalties, and equity interests tied to mining projects. Its assets cover gold, silver, and copper production across North America, South America, Africa, and Australia, operating with a low-risk model that avoids direct mining operations.

ARWR vs RGLD — Head-to-Head

Bigger by revenue
RGLD
RGLD
1.4× larger
RGLD
$375.3M
$264.0M
ARWR
Growing faster (revenue YoY)
ARWR
ARWR
+10376.0% gap
ARWR
10461.3%
85.3%
RGLD
Higher net margin
RGLD
RGLD
13.3% more per $
RGLD
24.9%
11.7%
ARWR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ARWR
ARWR
RGLD
RGLD
Revenue
$264.0M
$375.3M
Net Profit
$30.8M
$93.6M
Gross Margin
64.6%
Operating Margin
15.5%
56.2%
Net Margin
11.7%
24.9%
Revenue YoY
10461.3%
85.3%
Net Profit YoY
117.8%
-12.8%
EPS (diluted)
$0.22
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARWR
ARWR
RGLD
RGLD
Q4 25
$264.0M
$375.3M
Q3 25
$252.1M
Q2 25
$209.6M
Q1 25
$193.4M
Q4 24
$202.6M
Q3 24
$193.8M
Q2 24
$174.1M
Q1 24
$148.9M
Net Profit
ARWR
ARWR
RGLD
RGLD
Q4 25
$30.8M
$93.6M
Q3 25
$126.8M
Q2 25
$132.3M
Q1 25
$113.5M
Q4 24
$107.4M
Q3 24
$96.2M
Q2 24
$81.2M
Q1 24
$47.2M
Gross Margin
ARWR
ARWR
RGLD
RGLD
Q4 25
64.6%
Q3 25
73.6%
Q2 25
72.6%
Q1 25
69.4%
Q4 24
70.3%
Q3 24
66.6%
Q2 24
64.7%
Q1 24
58.4%
Operating Margin
ARWR
ARWR
RGLD
RGLD
Q4 25
15.5%
56.2%
Q3 25
64.4%
Q2 25
67.7%
Q1 25
63.6%
Q4 24
65.9%
Q3 24
61.3%
Q2 24
58.6%
Q1 24
50.7%
Net Margin
ARWR
ARWR
RGLD
RGLD
Q4 25
11.7%
24.9%
Q3 25
50.3%
Q2 25
63.1%
Q1 25
58.7%
Q4 24
53.0%
Q3 24
49.7%
Q2 24
46.6%
Q1 24
31.7%
EPS (diluted)
ARWR
ARWR
RGLD
RGLD
Q4 25
$0.22
$1.04
Q3 25
$1.92
Q2 25
$2.01
Q1 25
$1.72
Q4 24
$1.63
Q3 24
$1.46
Q2 24
$1.23
Q1 24
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARWR
ARWR
RGLD
RGLD
Cash + ST InvestmentsLiquidity on hand
$715.0M
$233.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$568.4M
$7.2B
Total Assets
$1.6B
$9.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARWR
ARWR
RGLD
RGLD
Q4 25
$715.0M
$233.7M
Q3 25
$172.8M
Q2 25
$248.2M
Q1 25
$240.8M
Q4 24
$195.5M
Q3 24
$127.9M
Q2 24
$74.2M
Q1 24
$137.9M
Total Debt
ARWR
ARWR
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$50.0M
Q1 24
Stockholders' Equity
ARWR
ARWR
RGLD
RGLD
Q4 25
$568.4M
$7.2B
Q3 25
$3.4B
Q2 25
$3.3B
Q1 25
$3.2B
Q4 24
$3.1B
Q3 24
$3.0B
Q2 24
$3.0B
Q1 24
$2.9B
Total Assets
ARWR
ARWR
RGLD
RGLD
Q4 25
$1.6B
$9.5B
Q3 25
$4.5B
Q2 25
$3.6B
Q1 25
$3.5B
Q4 24
$3.4B
Q3 24
$3.3B
Q2 24
$3.3B
Q1 24
$3.3B
Debt / Equity
ARWR
ARWR
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARWR
ARWR
RGLD
RGLD
Operating Cash FlowLast quarter
$13.5M
$241.7M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
0.44×
2.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARWR
ARWR
RGLD
RGLD
Q4 25
$13.5M
$241.7M
Q3 25
$174.0M
Q2 25
$152.8M
Q1 25
$136.4M
Q4 24
$141.1M
Q3 24
$136.7M
Q2 24
$113.5M
Q1 24
$138.3M
Free Cash Flow
ARWR
ARWR
RGLD
RGLD
Q4 25
$11.3M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
ARWR
ARWR
RGLD
RGLD
Q4 25
4.3%
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
ARWR
ARWR
RGLD
RGLD
Q4 25
0.8%
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
ARWR
ARWR
RGLD
RGLD
Q4 25
0.44×
2.58×
Q3 25
1.37×
Q2 25
1.15×
Q1 25
1.20×
Q4 24
1.31×
Q3 24
1.42×
Q2 24
1.40×
Q1 24
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARWR
ARWR

Segment breakdown not available.

RGLD
RGLD

Gold$216.9M58%
Pueblo Viejo$47.3M13%
Andacollo$32.6M9%
Silver$32.1M9%
Other$27.2M7%
Copper$13.7M4%
Cortez Legacy Zone$5.4M1%

Related Comparisons